CFAP161
gene geneOn this page
Also known as FLJ38615
Summary
CFAP161 (cilia and flagella associated protein 161, HGNC:26782) is a protein-coding gene on chromosome 15q25.1, encoding Cilia- and flagella-associated protein 161 (Q6P656). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Predicted to be involved in cilium assembly and flagellated sperm motility. Predicted to act upstream of or within gene expression; mRNA stabilization; and motile cilium assembly. Located in axonemal microtubule.
Source: NCBI Gene 161502 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 54 total
- GTEx eGene: eQTL in 12 tissues, sQTL in 3 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.03 (unconstrained)
- MANE Select transcript:
NM_173528 - Notable: 54 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26782 |
| Approved symbol | CFAP161 |
| Name | cilia and flagella associated protein 161 |
| Location | 15q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38615 |
| Ensembl gene | ENSG00000156206 |
| Ensembl biotype | protein_coding |
| Entrez | 161502 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
MANE Select: ENST00000286732
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 4: 1, TSL 5: 1
ENST00000286732, ENST00000560091, ENST00000561216
RefSeq mRNA: 2 — MANE Select: NM_173528
NM_001353365, NM_173528
CCDS: CCDS42068
Canonical transcript exons
ENST00000286732 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001253114 | 81143662 | 81143820 |
| ENSE00001253121 | 81138051 | 81138135 |
| ENSE00002434177 | 81148338 | 81149179 |
| ENSE00002530819 | 81147858 | 81147931 |
| ENSE00002561855 | 81134270 | 81134398 |
| ENSE00003663949 | 81135270 | 81135359 |
| ENSE00003788617 | 81136516 | 81136748 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 87.95.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2839 / max 144.8573, expressed in 252 samples.
Highest expression (Bgee): uterine tube, monocyte, leukocyte, bronchial epithelial cell, male germ line stem cell (sensu Vertebrata) in testis.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CFAP161 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 12 tissues and its splicing (sQTL) in 3 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
15 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Testis | eqtl | 1.1e-14 | +0.88 | 15:81134296:G:A |
| Whole Blood | eqtl | 5.7e-11 | -0.31 | 15:81135816:G:A |
| Heart Atrial Appendage | eqtl | 1.0e-09 | -0.45 | 15:81105706:A:T |
| Lung | eqtl | 1.8e-08 | -0.22 | 15:81116176:C:T |
| Heart Left Ventricle | eqtl | 2.8e-07 | -0.35 | 15:81114074:T:C |
| Thyroid | eqtl | 3.0e-07 | -0.33 | 15:81129669:G:A |
| Testis | sqtl | 2.0e-06 | -0.74 | 15:81147297:C:A |
| Pituitary | eqtl | 4.5e-04 | +0.82 | 15:81134296:G:A |
| Pituitary | sqtl | 1.1e-03 | -0.72 | 15:81147297:C:A |
| Brain Cortex | eqtl | 1.0e-02 | +1.54 | 15:81134296:G:A |
| Lung | sqtl | 2.1e-02 | +0.27 | 15:81116176:C:T |
| Esophagus Muscularis | eqtl | 3.3e-02 | +0.38 | 15:80594143:G:A |
| Adipose Visceral Omentum | eqtl | 3.6e-02 | -0.20 | 15:81116176:C:T |
| Skin Not Sun Exposed Suprapubic | eqtl | 4.5e-02 | -0.22 | 15:81113282:G:A |
| Brain Caudate basal ganglia | eqtl | 4.7e-02 | -0.20 | 15:80392626:C:T |
FANTOM5 promoters
7 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 148061 | 0.6829 | 108 |
| 148062 | 0.1771 | 51 |
| 148060 | 0.1313 | 50 |
| 148057 | 0.1175 | 38 |
| 148059 | 0.0988 | 48 |
| 148063 | 0.0553 | 29 |
| 148056 | 0.0210 | 6 |
Top tissues by expression
showing 100 of 245 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 87.95 | gold quality |
| monocyte | CL:0000576 | 87.55 | gold quality |
| leukocyte | CL:0000738 | 86.04 | gold quality |
| bronchial epithelial cell | CL:0002328 | 85.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.01 | gold quality |
| bronchus | UBERON:0002185 | 83.86 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 82.96 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 78.63 | gold quality |
| fallopian tube | UBERON:0003889 | 69.43 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 69.25 | gold quality |
| nasopharynx | UBERON:0001728 | 69.24 | gold quality |
| left testis | UBERON:0004533 | 68.34 | gold quality |
| right testis | UBERON:0004534 | 67.27 | gold quality |
| oviduct epithelium | UBERON:0004804 | 67.24 | gold quality |
| testis | UBERON:0000473 | 67.19 | gold quality |
| right lung | UBERON:0002167 | 66.32 | gold quality |
| sperm | CL:0000019 | 66.18 | silver quality |
| granulocyte | CL:0000094 | 65.59 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.22 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 64.41 | gold quality |
| upper lobe of lung | UBERON:0008948 | 64.03 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 63.45 | gold quality |
| adenohypophysis | UBERON:0002196 | 62.54 | gold quality |
| lung | UBERON:0002048 | 61.49 | gold quality |
| pituitary gland | UBERON:0000007 | 61.02 | gold quality |
| calcaneal tendon | UBERON:0003701 | 60.04 | gold quality |
| secondary oocyte | CL:0000655 | 59.00 | gold quality |
| lower lobe of lung | UBERON:0008949 | 58.48 | silver quality |
| hypothalamus | UBERON:0001898 | 58.07 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 58.03 | gold quality |
| blood | UBERON:0000178 | 57.66 | gold quality |
| caput epididymis | UBERON:0004358 | 57.53 | gold quality |
| apex of heart | UBERON:0002098 | 56.32 | gold quality |
| corpus callosum | UBERON:0002336 | 55.37 | gold quality |
| heart left ventricle | UBERON:0002084 | 55.03 | gold quality |
| cardiac ventricle | UBERON:0002082 | 54.53 | gold quality |
| mucosa of stomach | UBERON:0001199 | 54.38 | gold quality |
| nucleus accumbens | UBERON:0001882 | 54.37 | gold quality |
| caudate nucleus | UBERON:0001873 | 54.05 | gold quality |
| left uterine tube | UBERON:0001303 | 53.48 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 53.21 | gold quality |
| endocervix | UBERON:0000458 | 53.16 | gold quality |
| heart | UBERON:0000948 | 52.76 | gold quality |
| endometrium | UBERON:0001295 | 52.57 | gold quality |
| tendon | UBERON:0000043 | 52.51 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.28 | gold quality |
| peritoneum | UBERON:0002358 | 51.13 | gold quality |
| omental fat pad | UBERON:0010414 | 51.12 | gold quality |
| right atrium auricular region | UBERON:0006631 | 51.07 | gold quality |
| cardiac atrium | UBERON:0002081 | 50.79 | gold quality |
| Ammon’s horn | UBERON:0001954 | 50.60 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 50.58 | gold quality |
| ventricular zone | UBERON:0003053 | 50.51 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 50.51 | gold quality |
| forebrain | UBERON:0001890 | 50.13 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 49.52 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 49.51 | gold quality |
| brain | UBERON:0000955 | 49.40 | gold quality |
| amygdala | UBERON:0001876 | 49.12 | gold quality |
| thyroid gland | UBERON:0002046 | 48.68 | gold quality |
| adult organism | UBERON:0007023 | 48.54 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 48.50 | gold quality |
| right frontal lobe | UBERON:0002810 | 48.47 | gold quality |
| neocortex | UBERON:0001950 | 48.42 | gold quality |
| frontal cortex | UBERON:0001870 | 48.26 | gold quality |
| uterus | UBERON:0000995 | 48.12 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 48.10 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 47.95 | gold quality |
| cerebral cortex | UBERON:0000956 | 47.93 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 47.88 | silver quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 47.79 | gold quality |
| anatomical system | UBERON:0000467 | 47.62 | gold quality |
| cerebellar cortex | UBERON:0002129 | 47.62 | silver quality |
| material anatomical entity | UBERON:0000465 | 47.56 | gold quality |
| multicellular organism | UBERON:0000468 | 47.55 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 47.42 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 47.36 | gold quality |
| left coronary artery | UBERON:0001626 | 47.22 | gold quality |
| right lobe of liver | UBERON:0001114 | 47.14 | gold quality |
| cerebellum | UBERON:0002037 | 47.10 | silver quality |
| adipose tissue | UBERON:0001013 | 47.07 | gold quality |
| spinal cord | UBERON:0002240 | 47.07 | gold quality |
| substantia nigra | UBERON:0002038 | 46.80 | gold quality |
| liver | UBERON:0002107 | 46.60 | silver quality |
| body of pancreas | UBERON:0001150 | 46.57 | gold quality |
| coronary artery | UBERON:0001621 | 46.56 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 46.46 | gold quality |
| spleen | UBERON:0002106 | 46.41 | gold quality |
| lower esophagus | UBERON:0013473 | 46.33 | gold quality |
| pancreas | UBERON:0001264 | 46.26 | gold quality |
| placenta | UBERON:0001987 | 46.11 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 46.07 | silver quality |
| midbrain | UBERON:0001891 | 46.03 | gold quality |
| uterine cervix | UBERON:0000002 | 46.00 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 45.86 | silver quality |
| islet of Langerhans | UBERON:0000006 | 45.75 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 45.48 | gold quality |
| tibial artery | UBERON:0007610 | 45.45 | gold quality |
| temporal lobe | UBERON:0001871 | 45.37 | gold quality |
| tonsil | UBERON:0002372 | 45.35 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.77 |
HPA expression
RNA tissue specificity: Group enriched
showing 60 of 73 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Choroid plexus | tissue | 80.5 | high |
| Periaqueductal gray | tissue | 15.8 | |
| Fallopian tube | tissue | 14.9 | high |
| Hippocampal formation | tissue | 8.8 | |
| Basal ganglia | tissue | 8.4 | not detected |
| Nucleus accumbens | tissue | 6.4 | |
| Postcentral gyrus | tissue | 6.2 | |
| Testis | tissue | 6.0 | low |
| Hypothalamus | tissue | 4.4 | |
| Locus coeruleus | tissue | 4.3 | |
| Amygdala | tissue | 4.2 | |
| Septum | tissue | 4.1 | |
| Putamen | tissue | 3.9 | |
| Pons | tissue | 3.7 | |
| Corpus callosum | tissue | 3.7 | |
| Caudate putamen | tissue | 3.7 | |
| Ventral forebrain | tissue | 3.3 | |
| Thalamus | tissue | 3.2 | |
| Prefrontal cortex | tissue | 2.9 | |
| Cerebral cortex | tissue | 2.9 | low |
| Insular cortex | tissue | 2.9 | |
| Temporal cortex | tissue | 2.8 | |
| Retrosplenial and cingulate cortex | tissue | 2.7 | |
| Lung | tissue | 2.5 | not detected |
| Motor cortex | tissue | 2.4 | |
| Hippocampus | tissue | 2.3 | low |
| Entorhinal cortex | tissue | 2.3 | |
| Retrosplenial cortex | tissue | 2.2 | |
| Medulla oblongata | tissue | 2.1 | |
| Cerebellum | tissue | 1.8 | not detected |
| Midbrain | tissue | 1.7 | |
| Somatosensory cortex | tissue | 1.7 | |
| Pituitary gland | tissue | 1.6 | |
| Superior colliculi | tissue | 1.6 | |
| Olfactory bulb | tissue | 1.4 | |
| Occipital cortex | tissue | 1.3 | |
| Retina | tissue | 1.2 | medium |
| Placenta | tissue | 1.2 | low |
| Spinal cord | tissue | 1.0 | |
| Substantia nigra | tissue | 0.8 | |
| Tongue | tissue | 0.7 | |
| Heart muscle | tissue | 0.6 | low |
| Epididymis | tissue | 0.6 | not detected |
| Endometrium 1 | tissue | 0.5 | not detected |
| Thyroid gland | tissue | 0.5 | not detected |
| Spleen | tissue | 0.5 | not detected |
| Bone marrow | tissue | 0.5 | not detected |
| Cervix | tissue | 0.4 | not detected |
| Skin 1 | tissue | 0.4 | not detected |
| Adipose tissue | tissue | 0.4 | not detected |
| Parathyroid gland | tissue | 0.3 | not detected |
| Frontal cortex | tissue | 0.3 | |
| Breast | tissue | 0.2 | not detected |
| Stomach 1 | tissue | 0.2 | not detected |
| Seminal vesicle | tissue | 0.2 | not detected |
| Salivary gland | tissue | 0.2 | not detected |
| Skeletal muscle | tissue | 0.2 | not detected |
| Smooth muscle | tissue | 0.2 | not detected |
| Urinary bladder | tissue | 0.2 | not detected |
| Liver | tissue | 0.2 | not detected |
Brain sub-regions (HPA Brain Atlas): detected in 190; highest nTPM — Vermis (13.0), Cerebellar cortex (11.7), Periaquaductal grey, lateral (11.6), Cervical spinal cord, central gray (10.8), Flocculonodular lobe (10.3).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CFAP161 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 41 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-2053 | 99.57 | 69.15 | 1635 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4650-3P | 99.01 | 68.39 | 1062 |
| HSA-MIR-154-5P | 98.92 | 66.65 | 733 |
| HSA-MIR-873-5P | 98.84 | 66.90 | 1348 |
| HSA-MIR-4451 | 98.82 | 68.17 | 1455 |
| HSA-MIR-455-5P | 98.74 | 67.31 | 795 |
| HSA-MIR-12114 | 98.70 | 63.45 | 730 |
Functional genomics
gnomAD constraint: pLI 0.00035, LOEUF 1.03, missense Z 0.219 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000286732 — one region, missense o/e 0.99.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap161 | ENSDARG00000018281 |
| mus_musculus | Cfap161 | ENSMUSG00000011154 |
| rattus_norvegicus | Cfap161 | ENSRNOG00000012301 |
| drosophila_melanogaster | CG15498 | FBGN0038892 |
| drosophila_melanogaster | CG34457 | FBGN0085486 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1922806) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 7 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal mouth morphology | 1 |
| abnormal mammary gland morphology | 1 |
| abnormal thyroid gland morphology | 1 |
| abnormal spleen morphology | 1 |
| enlarged spleen | 1 |
| enlarged thyroid gland | 1 |
| decreased total body fat amount | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | F6RJC2 | 81.6% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| TMC3-AS1 | ncRNA | 101929655 |
| TMC3 | protein-coding | 342125 |
| IL16 | protein-coding | 3603 |
| TLNRD1 | protein-coding | 59274 |
| STARD5 | protein-coding | 80765 |
| MIR4514 | ncRNA | 100616181 |
| MESD | protein-coding | 23184 |
| CEMIP | protein-coding | 57214 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 161 — Q6P656 (reviewed: Q6P656)
All UniProt accessions (3): H0YM05, H0YNS7, Q6P656
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme.
Tissue specificity. Expressed in airway epithelial cells.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6P656-1 | 1 | yes |
| Q6P656-2 | 2 |
RefSeq proteins (2): NP_001340294, NP_775799* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR055325 | CF161 | Family |
Pfam: PF24569
UniProt features (6 total): splice variant 3, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
2 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 7UNG | 48-nm repeat of the human respiratory doublet microtubule | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | 96nm repeat of human respiratory doublet microtubule and associated axonemal complexes | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P656-F1 | 87.29 | 0.63 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH supported
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 78 (showing top):
FREAC2_01, SP3_Q3, AAAYRNCTG_UNKNOWN, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_ORGANIZATION, GATA6_01, GOBP_CILIUM_MOVEMENT, TCF11_01, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, HP1SITEFACTOR_Q6, GOBP_ORGANELLE_ASSEMBLY, NKX22_01, P300_01, GOBP_CELL_PROJECTION_ORGANIZATION, TGGAAA_NFAT_Q4_01
GO Biological Process (2): flagellated sperm motility (GO:0030317), cilium assembly (GO:0060271)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): axonemal microtubule (GO:0005879), motile cilium (GO:0031514), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), axoneme (GO:0005930)
GO top-level categories
22 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| binding | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| cilium | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 1 of 8 annotations. The rest are phylogenetic / computational / electronic (IEA).
1 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| axonemal microtubule | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 1,114 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP161 | LRRC46 | Q96FV0 | 620 |
| CFAP161 | TEKTIP1 | A6NCJ1 | 590 |
| CFAP161 | CFAP53 | Q96M91 | 550 |
| CFAP161 | CFAP20 | Q9Y6A4 | 545 |
| CFAP161 | PEBP4 | Q96S96 | 530 |
| CFAP161 | C20orf202 | A1L168 | 530 |
| CFAP161 | EFHC1 | Q5JVL4 | 530 |
| CFAP161 | SPAG8 | Q99932 | 530 |
| CFAP161 | ODF2 | Q5BJF6 | 527 |
| CFAP161 | RSPH14 | Q9UHP6 | 523 |
| CFAP161 | LRRC23 | Q53EV4 | 513 |
| CFAP161 | SPATA18 | Q8TC71 | 504 |
| CFAP161 | CCDC146 | Q8IYE0 | 490 |
| CFAP161 | EFHC2 | Q5JST6 | 490 |
| CFAP161 | LRRC34 | Q8IZ02 | 488 |
IntAct
Human interaction partners of CFAP161 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
13 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| DPYSL5 | physical association | 0.640 | 4 |
| EFHC1 | physical association | 0.560 | 5 |
| BCL6 | physical association | 0.560 | 3 |
| CINP | physical association | 0.560 | 3 |
| NBN | association | 0.350 | 1 |
| AFG2A | physical association | 0.000 | 1 |
| AFG2B | physical association | 0.000 | 1 |
| BUB1 | physical association | 0.000 | 1 |
| CCDC150 | physical association | 0.000 | 1 |
| DCTPP1 | physical association | 0.000 | 1 |
| EML5 | physical association | 0.000 | 1 |
| MRE11 | physical association | 0.000 | 1 |
| RAD50 | physical association | 0.000 | 1 |
Disease & clinical
Genetic variants
Variant evidence for CFAP161: 54 ClinVar records (0 pathogenic / likely pathogenic); 5 GWAS associations.
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 4 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 36 predictions of 587):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 15:81136554–81136555 | acceptor_gain | 1.0000 | 2 |
| 15:81134399–81134400 | donor_loss | 0.9900 | 4 |
| 15:81135268–81135269 | acceptor_loss | 0.9900 | 5 |
| 15:81135360–81135361 | donor_loss | 0.9900 | 6 |
| 15:81136514–81136515 | acceptor_loss | 0.9900 | 6 |
| 15:81136749–81136750 | donor_loss | 0.9900 | 5 |
| 15:81143821–81143822 | donor_loss | 0.9900 | 5 |
| 15:81134399 | donor_loss | 0.9800 | |
| 15:81135269 | acceptor_loss | 0.9800 | |
| 15:81136513 | acceptor_loss | 0.9800 |
AlphaMissense
397 missense substitutions predicted likely pathogenic (of 1,989 scored), across 136 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| H221 | 8 | 0.873 | 0.954 |
| N262 | 8 | 0.849 | 0.969 |
| W15 | 7 | 0.962 | 0.983 |
| W193 | 7 | 0.961 | 0.983 |
| W264 | 7 | 0.953 | 0.987 |
| F29 | 7 | 0.893 | 0.978 |
| F127 | 7 | 0.882 | 0.962 |
| E17 | 7 | 0.816 | 0.908 |
| E243 | 7 | 0.813 | 0.895 |
| F240 | 7 | 0.805 | 0.936 |
| E245 | 7 | 0.802 | 0.884 |
| F147 | 6 | 0.891 | 0.967 |
| N125 | 6 | 0.795 | 0.936 |
| D253 | 6 | 0.793 | 0.874 |
| E258 | 6 | 0.788 | 0.864 |
| G36 | 6 | 0.747 | 0.882 |
| S164 | 5 | 0.963 | 0.986 |
| R124 | 5 | 0.892 | 0.949 |
| S114 | 5 | 0.862 | 0.971 |
| T224 | 5 | 0.847 | 0.964 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Uterine Corpus Endometrial Carcinoma)
Disease associations
OMIM: gene `` | disease phenotypes:
GWAS associations
5 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST010866_34 | Coronary artery disease | 4e-10 |
| GCST005951_20 | Body mass index | 2e-8 |
| GCST010242_141 | HDL cholesterol levels | 3e-8 |
| GCST011365_143 | Myocardial infarction | 7e-7 |
| GCST010396_289 | Gut microbiota (bacterial taxa, hurdle binary method) | 6e-6 |
EFO canonical traits (from GWAS)
3 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression | 2 |
| Smoke | increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| monobutyl phthalate | decreases methylation, increases abundance | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression | 1 |
| monomethylpropion | affects expression | 1 |
| mono-benzyl phthalate | decreases methylation, increases abundance | 1 |
| abrine | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Arbutin | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Coal | increases abundance, increases expression | 1 |
| Cuprizone | increases expression, affects cotreatment | 1 |
| Haloperidol | increases expression, affects cotreatment | 1 |
| Phthalic Acids | decreases methylation, increases abundance | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.